Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: HBIO Harvard Bioscience

No earlier versions found for this Subject.

Return to HBIO Harvard Bioscience

harvardapparatus.com

With some 10,000 products on its roster, Harvard Bioscience makes tools that aid in the drug-development process. One focus is protein purification. Another focus is ADMET (absorption, distribution, metabolism, elimination, and toxicology): It sells tests to screen drug candidates for these qualities. Subsidiary Biochrom makes instruments such as spectrophotometers, amino acid analyzers, and protein calculators. The firm sells its products directly in Canada, France, Germany, the UK, and the US, and through distributors elsewhere around the world. APBiotech has a distribution deal with the firm and accounts for almost 40% of its sales. Christopher Dick controls 25% of the firm; CEO Chane Graziano owns nearly 20%.